Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 31 tags : Trial save search
Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit
Published: 2021-08-31 (Crawled : 17:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 1.4%
H: 0.28%
C: -20.44%
phase 1 car-t results trial phase 2 phase 3
Eagle Pharmaceuticals Wins Vasopressin Patent Trial
Published: 2021-08-31 (Crawled : 17:00) - biospace.com/
EGRX | $4.58 -3.98% -4.15% 95K
|
Health Technology
|
| O: 6.69%
H: 7.43%
C: 3.31%
patent trial
Adial Pharmaceuticals Exceeds Enrollment Target in ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients with Alcohol Use DisorderONWARD trial enrollment closed; trial completion expected in Q1 2022
Published: 2021-08-31 (Crawled : 17:00) - biospace.com/
ADIL | News | $1.72 1.18% 1.16% 140K
|
Health Technology
|
| O: 2.54%
H: 3.19%
C: -3.19%
alcohol use disorder treatment phase 3 trial enroll
J&J's HIV Vaccine Fails to Protect High-Risk African Women in Trial
Published: 2021-08-31 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.1%
H: 0.58%
C: -0.21%
risk women vaccine trial hiv
Industrial Floor Coating Market to Reach $9.48 Bn, Globally, by 2030 at 4.8% CAGR: AMR
Published: 2021-08-31 (Crawled : 14:00) - prnewswire.com
RPM | $107.93 0.06% 0.0% 600K
|
Process Industries
|
| O: -0.16%
H: 0.32%
C: -1.44%
trial
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study
Published: 2021-08-31 (Crawled : 14:00) - biospace.com/
PMCB | $2.13 1.4% 12K
|
Manufacturing
|
| O: 2.12%
H: 2.08%
C: 0.0%
ongoing biotech iot trial
Adial Pharmaceuticals Exceeds Enrollment Target in ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients with Alcohol Use Disorder
Published: 2021-08-31 (Crawled : 14:00) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K
|
Health Technology
|
| O: 2.54%
H: 3.19%
C: -3.19%
alcohol use disorder treatment phase 3 trial enroll
Tauriga Sciences, Inc. Initiates Clinical Trial to Examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum
Published: 2021-08-31 (Crawled : 12:15) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
women trial diagnostic
Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline
Published: 2021-08-31 (Crawled : 12:15) - globenewswire.com
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: -0.54%
H: 15.22%
C: 15.22%
chinese trial pharma
Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting
Published: 2021-08-31 (Crawled : 12:00) - globenewswire.com
CYTK | $66.76 1.82% 1.78% 810K
|
Health Technology
|
| O: 0.21%
H: 2.02%
C: 0.73%
clinical trials results trial
Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa
Published: 2021-08-31 (Crawled : 12:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.1%
H: 0.58%
C: -0.21%
phase 2 women results vaccine phase 2b trial hiv africa
Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa
Published: 2021-08-31 (Crawled : 11:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.1%
H: 0.58%
C: -0.21%
phase 2 women results vaccine phase 2b trial hiv africa
Velodyne Lidar and MOV.AI Partner to Provide Autonomous Solutions for Industrial and E-Commerce Robotics
Published: 2021-08-31 (Crawled : 11:00) - velodynelidar.com
VLDR | $1.26 2.38% 0
|
Electronic Technology
|
| O: -0.31%
H: 3.06%
C: 1.07%
autonomous trial lidar
Industrial Starch Market Size Worth $167.50 Billion By 2028 | CAGR: 7.0%: Grand View Research, Inc.
Published: 2021-08-31 (Crawled : 09:00) - prnewswire.com
INGR G | $115.1 0.67% 0.0% 190K
|
Process Industries
|
| O: 0.16%
H: 0.9%
C: -0.06%
research trial
Relief Reports that U.S. Collaboration Partner has Announced a New Finding from Aviptadil Phase 2b/3 Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19
Published: 2021-08-31 (Crawled : 07:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: -1.11%
H: 8.62%
C: 8.07%
covid phase 2 collaboration respiratory phase 2b trial aviptadil
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.